Invesaro

Stocks CARG Financial statements

Financial statements

CarGurus, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CarGurus, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1983174545895519511,655698798907
Cost of revenue17.624.836.342.729499761.870.365.5
Gross profit189299429553509657658637728842
Research and development11.522.547.969.585.7106124137139138
Selling and marketing154236316394257291337278307341
General and administrative12.822.739.550.462.297.773.195103101
Operating expenses180284406518411509549516571597
Operating income8.5715.323.234.397.8148108120157244
Interest expense0.030.03
Interest income0.420.872.282.981.080.123.8518.412.29.15
Other non-operating income0.370.562.294.381.351.092.8818.811.28.39
Pre-tax income8.9515.825.538.799.1149111139168253
Income tax2.452.64-39.7-3.4421.63932.446.739.656.1
Net income6.513.265.242.177.610984.436.921156
EBITDA10.619.128.242.1108189154169183273
EPS, basic-0.580.130.600.380.690.001.640.270.201.58
EPS, diluted-0.580.120.570.370.680.000.620.190.201.55
Shares, basic (weighted)44.155.810911111311711811310598.8
Shares, diluted (weighted)44.160.6113113114117128114106100

Balance sheet

FY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents29.587.734.959.9190232470291304191
Short-term investments44.85020.70
Receivables6.6512.613.622.118.218946.84038.341.9
Inventory19.75.280.330.34
Other current assets2.791.617.414.9712.416.42225.226.235.3
Total current assets85.5157195219332563557391391283
Property, plant and equipment12.816.624.32827.532.240.183.4124133
Lease right-of-use assets6060.860.656.9170121115
Goodwill15.229.115815715826.628.4
Intangible assets3.9210.983.953.123.14.023.25
Other non-current assets0.161.13.832.674.578.57.383.764.1
Total assets100177268394502932927919825662
Accounts payable16.423.934.336.721.666.232.547.921.829.1
Accrued liabilities8.3813.6
Deferred revenue3.334.318.819.989.1412.812.221.321.523.6
Total current liabilities29.14363.573.866.517198.711593.1101
Lease liabilities9.460.858.857.551.7182184181
Other non-current liabilities0.590.961.281.913.0823.65.34.7365.35
Total liabilities35.649.674.2137129252156302283288
Total debt00000
Paid-in capital3.7118518420524238841326316910.3
Retained earnings-71.7-58.59.7151.9129129323354375362
Other comprehensive income-0.030.230.07-0.351.88-0.4-1.64-0.9-2.551.43
Shareholders' equity-68127194257374517735617542374
Total equity-68127194257374517735617542374
Total liabilities and equity100177268394502932927919825662

Cash flow statement

FY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income6.513.265.242.177.61107922.121156
Depreciation and amortization2.073.85.037.8210.240.545.348.525.428.3
Stock-based compensation0.325.0320.834.345.153.554.863.762.350.4
Deferred income tax0.78-1.12-39-3.7322.26.16-22.1-21.4-7.6127.7
Change in receivables-1.43-7.04-1.91-9.613.89-17515311-4.870.68
Change in inventory-17.314.41.96-0.110.34
Change in payables5.816.249.354.27-15.135.4-352.08-4.663.56
Cash from operations2025.751.770.115798.3256125255295
Capital expenditures-5.85-5.16-5.96-11.2-2.95-7.71-5.92-24.6-75.2-6.38
Acquisitions-19.1-21.1-64.3
Purchases of investments-1200-98-0.490
Sales and maturities of investments1544.814018911213090
Cash from investing-52-12.6-80.3-22.3-16.9-68.172.7-61.6-73-29.3
Stock issued0.140.43.631.811.140.660.720.074.920.47
Share buybacks-60-14.4-209-146-352
Cash from financing0.6944.8-23.4-14.7-10.117.8-92.6-254-169-384
Exchange rate effect-0.050.16
Net change in cash-31.358-5233.213047.4236-19012.3-116
Free cash flow14.220.545.858.915490.6250100180289
Interest paid0.030.030.020.060.570.770.59
Income taxes paid2.054.392.310.32.8327.56174.840.819.8

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $31.30 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin92.3%Gross profit / revenue.
Operating margin28.6%Operating income / revenue.
EBITDA margin31.0%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin29.1%Pre-tax income / revenue.
Net margin18.2%Net income / revenue.
FCF margin32.6%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin33.0%Cash from operations / revenue.
Effective tax rate23.0%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)66.6%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)31.7%Net income / average total assets.
Return on invested capital (ROIC)149.9%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue14.8%Research and development expense / revenue.
Stock-based pay / revenue5.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.4%Capital expenditures / revenue.
D&A / revenue2.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y13.7%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-18.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y10.5%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y15.6%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y8.6%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y10.6%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y55.6%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y31.1%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y20.1%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y49.5%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y21.0%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y20.4%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y643.4%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y22.7%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y15.0%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y675.0%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y35.7%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y17.9%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y15.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y4.9%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y13.5%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y60.2%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y4.9%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y13.4%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-30.9%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-20.1%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y0.0%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-19.7%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-10.6%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y5.7%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-5.5%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-7.8%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-2.5%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.85xCurrent assets / current liabilities.
Quick ratio1.51x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.12x(Cash + short-term investments) / current liabilities.
Debt / equity0.00xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets0.0%Total debt / total assets.
Liabilities / assets52.4%Total liabilities / total assets.
Net debt-$122.1MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA-0.41xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital$93.1MCurrent assets - current liabilities.
Goodwill and intangibles / assets5.5%(Goodwill + intangible assets) / total assets.
Tangible book value$233.7MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.74xRevenue / average total assets.
Fixed asset turnover7.47xRevenue / average property, plant and equipment.
Receivables turnover22.1xRevenue / average receivables.
Days sales outstanding17 days365 x average receivables / revenue.
Days payables177 days365 x average accounts payable / cost of revenue.
FCF conversion179.2%Free cash flow / net income, when net income is positive.
Capex / operating cash flow1.1%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$1.84Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$10.62Revenue / diluted weighted shares.
FCF per share$3.46Free cash flow / diluted weighted shares.
Operating cash flow per share$3.50Cash from operations / diluted weighted shares.
Book value per share$2.90Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$2.57Tangible book value / shares outstanding.
Cash per share$1.34(Cash + short-term investments) / shares outstanding.
Buybacks / FCF117.2%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$2.79BShare price x shares outstanding.
Enterprise value$2.67BMarket cap + total debt - cash - short-term investments.
P/E15.8xMarket cap / net income. Only when net income is positive.
P/S2.88xMarket cap / revenue.
P/B10.5xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book11.9xMarket cap / tangible book value, when positive.
P/FCF8.84xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF8.75xMarket cap / cash from operations, when positive.
EV/Sales2.76xEnterprise value / revenue.
EV/EBIT9.63xEnterprise value / operating income, when both are positive.
EV/EBITDA8.88xEnterprise value / EBITDA, when both are positive.
EV/FCF8.46xEnterprise value / free cash flow, when both are positive.
FCF yield11.3%Free cash flow / market cap.
Earnings yield6.3%Net income / market cap (the inverse of P/E).
Shareholder yield13.3%(Dividends paid + share buybacks) / market cap.
PEG0.44xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was CarGurus, Inc.'s revenue in fiscal 2025?

CarGurus, Inc. reported revenue of $907.0M for fiscal 2025, 13.7% higher than the year before.

Was CarGurus, Inc. profitable in fiscal 2025?

Yes. Net income was $155.9M, a net margin of 17.2%.

How much free cash flow did CarGurus, Inc. generate in fiscal 2025?

Cash from operations of $295.3M minus capital expenditures of $6.4M left free cash flow of $288.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CarGurus, Inc.